A Follow-up Study to Evaluate the Safety of ALLO-ASC-CD in ALLO-ASC-CD-101 Clinical Trial
Clinical trial NCT03183661 · RECRUITING
Trial details
- NCT number
- NCT03183661
- Sponsor
- Anterogen Co., Ltd.
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2016-11-16
- Primary completion
- 2026-12-31
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.